(TheNewswire)
Kelowna, British Columbia – TheNewswire - Sept. 28, 2023 – Doseology SciencesInc. ( CSE: MOOD ) ( OTC: DOSEF ) ( FSE: VU7 ) (“Doseology” or the “Company”), Doseology, aninnovator in functional mushroom wellness products, is delighted toannounce the nationwide availability of its acclaimed MushroomTincture Line, featuring best sellers WAKE and SLEEP stacked formulasnow sold in 150+ Loblaw locations. As Canada's largest supermarketchain, Loblaw proudly offers these tinctures in their Natural Foods sections acrossmultiple banners like Real CanadianSuperstore and Fortinos .
“Our Mushroom Tinctures combine science and traditionwith the mushroom's whole fruiting body to offer a diverse range ofhealth benefits. Shawn Balaghi, CEO of Doseology, expresses enthusiasmfor this expanded partnership, which increases accessibility tohigh-quality natural health products.”
From immune support to stress relief and cognitiveenhancement, these tinctures are licensed by Health Canada, ensuringsafety and quality. With this expansion, Doseology remains committedto empowering individuals to enhance their mental health naturally.You can find our tinctures on the shelves of Loblaw storestoday.
Doseology's product line has expanded to respectedretailers across the nation. You can now find our products at Nature'sEmporium in Ontario, Commisso’s Fresh Foods in Ontario, Whole FoodsMarkets across Canada, select Sobeys and Safeways stores nationwide,and Nature’s Fare Markets in British Columbia.
As of Sept 2023, Doseology has established a presencein 300+ retail locations across Canada.
Additionally, we are excited to announce ourpartnership with Thrifty Foods, with an exciting launch planned forlate November 2023. Thrifty Foods currently operates approximately 28locations, primarily serving Vancouver Island and the Lower Mainlandof British Columbia.
For more information about Doseology Sciences and ourMushroom Tincture Product Line, please visit www.doseology.com .
About Doseology Sciences Inc. ( CSE: MOOD ) ( OTCQB: DOSEF ) ( FSE: VU7 )
Doseology specializes in premium functional mushroomand adaptogenic herbal supplements that are s tacked for targeted results. Ourproducts are science-backed and health expert-formulated, addressingtoday's top wellness needs. With 100% mushroom fruiting bodies formaximum purity and potency, we leave no room for compromise. Ourliquid format ensures faster absorption for an efficient wellnessexperience. At Doseology, we're committed to optimizing well-beingthrough the power of nature, offering investors an opportunity to joinour journey toward optimal wellness.
On behalf of the Board of Directors,
Shawn Balaghi
Chief Executive Officer
Doseology Sciences Inc
For further informationcontact:
Investor Relations: investor@doseology.com
Sales Inquiries: hello@doseology.com
Telephone: 236-349-0064
Website: doseology.com
Forward-Looking Statements
This press release contains statements that constitute“forward?looking information” within the meaning of applicablesecurities laws. Forward?looking information is often identified bythe words “may,” “would,” “could,” “should,”“will,” “intend,” “plan,” “anticipate,” “believe,”“estimate,” “expect” or similar expressions. Readers arecautioned that forward?looking information is not based onhistorical facts but instead reflects the Company’s management’sexpectations, estimates or projections concerning the business of theCompany’s future results or events based on the opinions,assumptions and estimates of management considered reasonable at thedate the statements are made. Although the Company believes that theexpectations reflected in such forward?looking information arereasonable, such information involves risks and uncertainties, andundue reliance should not be placed on such information, as unknown orunpredictable factors could have material adverse effects on futureresults, performance, or achievements. Among the key factors thatcould cause actual results to differ materially from those projectedin the forward?looking information are the following: changes ingeneral economic, business and political conditions, including changesin the financial markets; decreases in the prevailing prices forproducts in the markets that the Company operates in; adverse changesin applicable laws or adverse changes in the application orenforcement of current laws; regulations and enforcement priorities ofgovernmental authorities; compliance with government regulation andrelated costs; and other risks described in the Company’sprospectus. Should one or more of these risks or uncertaintiesmaterialize, or should assumptions underlying the forward?lookinginformation prove incorrect, actual results may vary materially fromthose described herein as intended, planned, anticipated, believed,estimated, or expected. Although the Company has attempted to identifyimportant risks, uncertainties and factors which could cause actualresults to differ materially, there may be others that cause resultsnot to be as anticipated, estimated or intended. The Company does notintend, and does not assume any obligation, to update thisforward?looking information except as otherwise required byapplicable law. For more information, investors should review theCompany’s filings which are available on SEDAR .
No securities regulatory authority has either approvedor disapproved of the contents of this press release. The Company’ssecurities have not been, nor will they be, registered under theUnited States Securities Act of 1933, as amended, or any statesecurities laws, and may not be offered or sold in the United States,or to or for the account or benefit of any person in the UnitedStates, absent registration, or an applicable exemption from theregistration requirements. This press release shall not constitute anoffer to sell or the solicitation of an offer to buy any securities inthe United States, or in any other jurisdiction in which such offer,solicitation or sale would be unlawful.
The CSE does not acceptresponsibility for the adequacy or accuracy of this release.
Copyright (c) 2023 TheNewswire - All rights reserved.